MondayMar 09, 2009 1:07 pm

EnterConnect Inc. (ECNI.OB) More Than Doubles its Business in 3rd Quarter; Updates Shareholders

A leading provider of business-ready SaaS (Software as a Service) portals, EnterConnect released its fiscal 2009 third quarter financial results in a press release also intended to bring its shareholders up to speed with regard to the latest company developments. For the three-month period ended December 31st, 2008, EnterConnect reported an astronomical rise of 104 percent in total revenues over the corresponding period in 2007. Gross profits also rose significantly, 86 percent, but the company has made it abundantly clear that these numbers are simply not enough. In an effort to increase sales, and the effectiveness of corporate strategies, the…

Continue Reading

MondayMar 09, 2009 12:44 pm

GreenChek Technology Inc. (GCHK.OB) Announces Manufacturing Expansion

GreenChek Technologies Inc., a provider of hydrogen fuel cell technology for commercial transportation and stationary power generation applications, announced today after the closing bell that Tianjin Sherma in Tianjin, China has committed a 4,000 square foot facility for the manufacture of GreenChek's ERD technology. Management expects the new state-of-the art manufacturing plant to be operational in eight weeks. With a determined production capacity of 1,050 units per production line per month, GreenChek Technologies will be able to generate roughly $50.4 million dollars in annual revenue per production line, at full capacity, at current prices. Management believes that its projected sales…

Continue Reading

MondayMar 09, 2009 11:21 am

American Oriental Bioengineering, Inc (AOB) is Thriving in Today’s Sluggish World Economy

American Oriental Bioengineering, Inc, (NYSE:AOB) announced today that its fourth quarter 2008 revenues were up a whopping 68% to $96.3 million. Net income for the same period was up 43% to $21.7 million. The good news reflects the continued demand for the company’s pharmaceutical and nutritional products in the Chinese marketplace. American Oriental, based in China, is engaged in the development and production of plant based products, both pharmaceutical and nutritional. The products are produced from the leaves and roots of various plants. In the case of PBPs (Plant Based Pharmaceuticals), they are used to treat illnesses or associated symptoms…

Continue Reading

MondayMar 09, 2009 10:26 am

SyntheMed, Inc. (SYMD.OB) Receives FDA Approval for REPEL-CV® Adhesion Barrier for Use in Pediatric Cardiac Surgery

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion products. SyntheMed reached a major milestone when the company announced that the U.S. Food and Drug Administration (FDA) has approved the Pre-Market Approval application for REPEL-CV® Adhesion Barrier for use in pediatric cardiac surgery patients. One of the unique aspects of REPEL-CV is that it is a bioresorbable film designed to be placed over the surface of the heart at the conclusion of an open-heart surgical procedure to reduce the formation of post-operative adhesions (scar tissue). Robert P. Hickey, who serves as the President and CEO…

Continue Reading

MondayMar 09, 2009 9:30 am

Convergence Technologies Group, Inc. (CNVC.PK) Brings Mechant Banking Services to its Clients

Convergence Technology Group, Inc. (CNVC.PK) recently announced details regarding its vision on how Bookkeeper International Equities Inc. will benefit small cap companies. Earlier this year, Convergence acquired Bookkeeper International, a private merchant banking group that specializes in corporate finance consulting services, merger and acquisition advisory services, and investor relations. Convergence believes that through the use of merchant banking and private equity, Bookkeeper International will provide a unique approach to support small cap companies trading in the U.S. capital markets. Traditionally merchant banks have been defined as a “European Financial Institution” based upon the geographic origins of the activity. The United…

Continue Reading

MondayMar 09, 2009 8:49 am

AM Oil Resources & Technology Inc.’s (AMOR.OB) Innovative Oil Recovery Technology and Market Position Earn a Speculative Buy Rating

AM Oil Resources & Technology Inc. (AMOR.OB) shares surged 7.69 percent to 28 cents in today’s mid-morning trading, moving on last week’s analyst rating by Beacon Equity Research. Beacon analyst Victor Sula recently gave the company a Speculative Buy rating, with a 63-cent target price, highlighting the company’s Portable Steam Generator System, Portable Thermo-Gas Repressurizing System and its Deep Steam Generator technologies. AMOR’s licensed technologies equip the company with a competitive edge as it emerges as an innovator in oil production from low-producing oil wells. According to the recent Beacon report, after 30 to 40 years of pumping, up to…

Continue Reading

MondayMar 09, 2009 7:40 am

Beacon Equity Research Featured Company: Perf Go Green Holdings Inc. (PGOG.OB)

Perf Go Green Holdings Inc., a company dedicated to funding green initiatives that promote sustainability, is a biodegradable plastics firm. They work at developing eco-friendly, non-toxic, food contact compliant, biodegradable plastic products as a solution to eliminate plastic waste from the environment. As part of the Green Revolution, they have developed a biodegradable trash bag. It consists of recycled plastics that are biodegradable. After consumers use them and have them hauled away to trash sites, the bags completely break down within 12 to 14 months. Perf Go Green markets and distributes a 13-gallon kitchen trash bag and a 30-gallon lawn…

Continue Reading

MondayMar 09, 2009 7:39 am

Beacon Equity Research Featured Company: Neohydro Technologies Corp. (NHYT.OB)

Neohydro Technologies Corp. is the exclusive licensee for the worldwide industrial applications of the Neohydro™ and Pathocell™ technologies. Neohydro Technologies is positioning to be the leading service company for providing economical end-to-end water supply solutions for industrial clients around the world. The Company is focusing their efforts on water sterilization technology. Neohydro is bringing a noninvasive, cost-efficient solution to industrial wastewater management. Improving the treatment of industrial water allows them to redefine the management, flexibility, efficiency, and cost-effectiveness of industrial water supply. They believe their technology will foster ethical and environmentally sound business practices and help alleviate the growing water…

Continue Reading

MondayMar 09, 2009 7:12 am

Cereplast, Inc. (CERP.OB) Contracted to Supply Bioplastics to Absorbent Specialty Products

Cereplast, Inc., a manufacturer of proprietary bio-based, sustainable plastics, announced that it will be supplying Absorbent Specialty Products with its bioplastic resin for the company’s new “Bio-Bones” Bone Replacement Prosthetics. “We’re very pleased that Absorbent Specialty Products selected our Compostables® resin for its Bio-bones product line,” said Frederic Scheer, Chairman and CEO of Cereplast. “It is encouraging to see more and more manufacturers developing and manufacturing products using sustainable alternatives to petroleum-based plastic products.” “We selected the Cereplast resin because of its natural ability to burn clean and turn to ash during cremation, as opposed to melting and emitting toxic…

Continue Reading

MondayMar 09, 2009 7:06 am

Mymetics Corp. (MYMX.OB) Announces Acquisition of Virosome Biologicals B.V.

Mymetics Corporation announced shortly after the opening bell today that it has signed a Share Purchase Agreement to acquire 100% of Bestewil Holding B.V., parent company of Virosome Biologicals B.V., from Norwood Immunology Limited (LSE:NIM). Virosome Biologicals B.V. is focused on developing a proprietary vaccine delivery platform (virosome) as well as intranasal influenza and RSV vaccines. As terms of the Share Purchase Agreement, Antonius Stegmann, co-founder and CSO of Virosome Biologicals B.V, will remain CSO of Virosome Biologicals B.V. The acquisition will expand Mymetics' current portfolio of vaccines, adding two collaborations: an Influenza vaccine in a Phase II Human Clinical…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered